Loading people...
Carl-Johan Dalsgaard is a Venture Partner at HealthCap, a European life sciences venture capital firm based in Stockholm, Sweden. Before joining the investment firm in late 2023, he served as the Chief Executive Officer of Vicore Pharma until September 2023. During his tenure, he led the biotechnology company through multiple funding rounds and clinical development phases for rare lung disease therapeutics. His corporate leadership experience includes serving as the Chief Executive Officer of Astra Pain Control, alongside various senior research leadership positions at AstraZeneca. He holds both a Doctor of Medicine and a Doctor of Philosophy from the Karolinska Institutet, where he previously worked as an Associate Professor and authored numerous peer-reviewed scientific publications during his academic career. Dalsgaard currently focuses on leveraging his biopharmaceutical executive experience to guide healthcare investments and support clinical-stage drug development companies.
Carl-Johan Dalsgaard is a distinguished Venture Partner at HealthCap, a prominent European venture capital firm exclusively focused on the life science sector. In this pivotal role, Carl-Johan contributes his profound scientific and commercial expertise to identify, evaluate, and nurture groundbreaking companies that are poised to revolutionize healthcare. His involvement is crucial in guiding portfolio companies through critical development stages, from early-stage research to clinical trials and market entry.
HealthCap, under the guidance of partners like Carl-Johan Dalsgaard, invests in a broad spectrum of life science innovations. Carl-Johan's specific investment focus areas align with HealthCap's mission to back companies developing novel therapeutics, diagnostics, and medical technologies. He is particularly interested in biotechnology and pharmaceutical ventures that address significant unmet medical needs, leveraging his deep understanding of drug discovery and development processes.
Carl-Johan's extensive career background provides a robust foundation for his role at HealthCap. Prior to joining the firm, he held several leadership positions that honed his strategic and operational skills in the pharmaceutical industry. Notably, he served as CEO of Pila Pharma and CEO of Action Pharma, where he was instrumental in advancing drug candidates through various development phases. His career also includes a significant tenure at Novo Nordisk, a global healthcare company, where he held various senior executive roles, including Corporate Vice President and Senior Vice President. These roles provided him with invaluable experience in global drug development, clinical operations, and commercial strategy across multiple therapeutic areas.
Educated as an MD and holding a PhD in Medical Sciences from the University of Copenhagen, Carl-Johan Dalsgaard combines a strong scientific background with practical business acumen. This unique blend allows him to critically assess the scientific merit of potential investments while also understanding the commercial viability and market potential. While specific notable investments directly led by Carl-Johan are often part of HealthCap's collective portfolio success, his expertise is vital in shaping the firm's investment decisions and providing strategic guidance to its portfolio companies, helping them navigate the complex landscape of drug development and market access. His contributions ensure that HealthCap continues to back companies with the potential to deliver significant patient benefits and strong financial returns.
Carl-Johan Dalsgaard is a highly experienced Venture Partner at HealthCap, a leading European life science venture capital firm. With a background as an MD and PhD, he brings deep expertise in drug development and commercialization to his role, supporting innovative healthcare companies.
As a Venture Partner at HealthCap, Carl-Johan Dalsgaard focuses on investments within the life science sector. His areas of interest include biotechnology, pharmaceuticals, medical technology, and novel therapeutics, particularly companies engaged in drug discovery and development.
Carl-Johan Dalsgaard works as a Venture Partner at HealthCap. HealthCap is a European venture capital firm dedicated to investing in life science companies, with offices in Stockholm, Sweden.
